1. Home
  2. DMRA vs CYD Comparison

DMRA vs CYD Comparison

Compare DMRA & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$24.85

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$41.95

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMRA
CYD
Founded
2011
1951
Country
United States
Singapore
Employees
7
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
DMRA
CYD
Price
$24.85
$41.95
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$46.00
$60.00
AVG Volume (30 Days)
217.1K
89.3K
Earning Date
04-30-2026
02-24-2026
Dividend Yield
N/A
1.27%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.11
Revenue Next Year
N/A
$8.67
P/E Ratio
N/A
$32.71
Revenue Growth
N/A
N/A
52 Week Low
$16.50
$14.76
52 Week High
$28.76
$56.55

Technical Indicators

Market Signals
Indicator
DMRA
CYD
Relative Strength Index (RSI) 46.18 49.21
Support Level $23.65 $40.53
Resistance Level $28.00 $45.94
Average True Range (ATR) 2.13 2.01
MACD -0.14 0.19
Stochastic Oscillator 28.16 37.75

Price Performance

Historical Comparison
DMRA
CYD

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: